Updates in relapsing-remitting MS from AAN 2025 examine neurofilament light protein level as a prognostic biomarker, safety and efficacy of ofatumumab, and benefit of early initiation of ozanimod.

The Patient-Centered Outcomes Research Institute (PCORI) gave the Cleveland Clinic $6.7 million to identify optimal RRMS ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS).

The world is full of nasty and deadly diseases, but some of the worst are the ones that turn your own body against you.

To provide the right treatment for multiple sclerosis (MS), it is important to know when the disease changes from ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

Having higher numbers of particular gut microbes might put you at a higher risk of developing multiple sclerosis (MS), a new ...

A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

Applegate went public with her multiple sclerosis diagnosis in 2021. She now co-hosts a podcast about life with MS, called “MeSsy,” alongside actor Jamie-Lynn Sigler. Sigler, best known for her role ...